PHP
MASS icon

Parkman Healthcare Partners’s 908 Devices MASS Stock Holding History

Parkman Healthcare Partners’s Portfolio MASS Stock Details MASS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,368
Closed -$879K – 107
2025
Q3 		$879K Buy
100,368
+368
+0.4% +$2.44K 0.09% 86
2025
Q2 		$713K Buy
+100,000
New +$556K 0.08% 86
2022
Q3 		– Sell
-149,315
Closed -$3.07M – 94
2022
Q2 		$3.07M Sell
149,315
-25,685
-15% -$432K 1.13% 30
2022
Q1 		$3.33M Buy
+175,000
New +$3.01M 0.97% 38

Other funds holding MASS

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

Parkman Healthcare Partners's MASS Position: Q4 2025 in Review

Parkman Healthcare Partners sold out of 908 Devices (MASS) in Q4 2025, closing a stake of 100,368 shares — an estimated $879K sold.

Parkman Healthcare Partners first reported a position in MASS in Q1 2022 and held it in 4 quarters. The position peaked at $3.33M in Q1 2022. 118 funds tracked by Wall St. Rank hold MASS as of Q4 2025.

  • Parkman Healthcare Partners reported no remaining 908 Devices position as of Q4 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 100,368 908 Devices shares in Q4 2025, an estimated $879K.
  • Parkman Healthcare Partners first reported a position in 908 Devices in Q1 2022 and held it in 4 quarters.
  • Parkman Healthcare Partners's 908 Devices position peaked at $3.33M in Q1 2022.
  • 118 funds tracked by Wall St. Rank held 908 Devices as of Q4 2025.

Based on Parkman Healthcare Partners's 13F filing for Q4 2025, filed 17 Feb 2026.